CV
CVS Group plc
CVSGF · OTC
$16.60 +0.00% (+$0.00)
Market Cap £845.3M
P/E Ratio 16.01x
Div. Yield 0.67%
ROE 18.92%
Bulios Fair Price
$21.88
31.8% upside
Current Price
$16.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CVSGF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
92 /100
Cheap PEG 0.02x
P/S 0.91x
P/B 2.82x
Growth
71 /100
Growing Rev. growth 18.58%
FCF growth 14.45%
Book val. growth 11.31%
Profitability
54 /100
Moderate Net margin 5.71%
Op. margin 10.67%
FCF margin 8.27%
Quality
62 /100
Average ROE 18.92%
ROA 5.52%
Asset turnover 0.97x
Debt
54 /100
Moderate Current ratio 1.10x
Int. coverage 2.90x
Net debt/EBITDA 2.04x
Stability
52 /100
Moderate Rev. volatility 20.11%
EPS volatility 209.18%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CVSGF
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Richard William Mark Fairman
Employees
9,000
Headquarters
Diss
Upcoming events
24 SEP
Earnings
Upcoming earnings report